Exelixis (EXEL) Liabilities and Shareholders Equity (2010 - 2026)

Exelixis (EXEL) recorded quarterly Liabilities and Shareholders Equity of $2.6 billion in Q2 2026, down 8.82% quarter-over-quarter from $2.8 billion in Q1 2026, and down 8.59% on a YoY basis from $2.8 billion in Q2 2025.

Exelixis (EXEL) Liabilities and Shareholders Equity (2010 - 2026) Analysis & Trends

Exelixis' Liabilities and Shareholders Equity history runs 17 years deep, the most recent figure standing at $2.6 billion for Q2 2026.

  • In Q2 2026, Liabilities and Shareholders Equity fell 8.59% year-over-year to $2.6 billion; the TTM figure through Apr 2026 stood at $10.9 billion (down 5.02% YoY), while the FY2026 annual figure was $2.8 billion, down 3.5% from the prior year.
  • Liabilities and Shareholders Equity was $2.6 billion for Q2 2026 at Exelixis, down from $2.8 billion in the prior quarter.
  • In the past five years, Liabilities and Shareholders Equity ranged from a high of $3.1 billion in Q1 2023 to a low of $2.6 billion in Q2 2026.
  • Historically, Liabilities and Shareholders Equity has averaged $2.9 billion across 5 years, with a median of $2.9 billion in 2022.
  • The sharpest annual moves came in 2022 and 2024: Liabilities and Shareholders Equity increased 21.72% in 2022, then decreased 11.75% in 2024.
  • A 5-year view of Liabilities and Shareholders Equity shows it stood at $3.1 billion in 2022, then decreased by 4.2% to $2.9 billion in 2023, then advanced by 0.61% to $3.0 billion in 2024, then slipped by 4.62% to $2.8 billion in 2025, then slipped by 8.14% to $2.6 billion in 2026.
  • The last three Liabilities and Shareholders Equity figures came in at $2.6 billion (Q2 2026), $2.8 billion (Q1 2026), and $2.8 billion (Q4 2025), per Business Quant data.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Liabilities and Shareholders Equity (Qtr)
1 Alterity Therapeutics 719,706.53 Bn 719,706.50 Bn - 37.37 Mn
2 Belite Bio 55,800.00 Bn 55,800.00 Bn - 811.27 Mn
3 Quantum Biopharma 18,182.30 Bn 18,182.29 Bn - 14.93 Mn
4 Legend Biotech 3,154.00 Bn 3,153.71 Bn 242.10 Mn 1.73 Bn
5 Akari Therapeutics 1,844.30 Bn 1,844.29 Bn - 33.89 Mn
6 Evaxion A 1,567.96 Bn 1,567.94 Bn - 23.64 Mn
7 Psyence Biomedical 251.43 Bn 251.42 Bn - 12.81 Mn
8 Vertex Pharmaceuticals 112.56 Bn 105.31 Bn 2.59 Bn 26.48 Bn
9 Abivax 94.37 Bn 94.37 Bn - 640.56 Mn
10 Exelixis 13.37 Bn 12.59 Bn 590.86 Mn 2.59 Bn

Historic Data

Download Data
DateValue
Apr 3, 2026 2.59 Bn
Jan 2, 2026 2.84 Bn
Oct 3, 2025 2.82 Bn
Jul 4, 2025 2.68 Bn
Apr 4, 2025 2.84 Bn
Jan 3, 2025 2.95 Bn
Sep 27, 2024 2.96 Bn
Jun 28, 2024 2.77 Bn
Mar 29, 2024 2.80 Bn
Dec 29, 2023 2.94 Bn
Sep 29, 2023 2.98 Bn
Jun 30, 2023 3.14 Bn
Mar 31, 2023 3.14 Bn
Dec 30, 2022 3.07 Bn
Sep 30, 2022 2.96 Bn
Jul 1, 2022 2.88 Bn
Apr 1, 2022 2.65 Bn
Dec 31, 2021 2.62 Bn
Oct 1, 2021 2.45 Bn
Jul 2, 2021 2.37 Bn